FindTrial
Sign In

Fingerstick

DIAGNOSTIC_TEST9 trials

Sponsors

Seventh Sense Biosystems, LumiraDx UK Limited, Icahn School of Medicine at Mount Sinai

Conditions

CardiovascularCovid19Deep Vein ThrombosisDiabetesEmbolism and ThrombosisGestational Diabetes, Controlled by DietInfectionInfections

Unknown Phase

A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick
NCT02045758
Seventh Sense BiosystemsDiabetes
Start: 2014-12-31End: 2015-09-30Target: 120Updated: 2014-09-03
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
NCT04375982
LumiraDx UK LimitedEmbolism and Thrombosis, Infection, Inflammation
Start: 2020-04-20End: 2024-03-31Target: 200Updated: 2023-12-26
Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag Test
NCT04557046
LumiraDx UK LimitedCovid19
Start: 2020-06-26End: 2024-03-31Updated: 2023-12-26
A Performance Evaluation of the LumiraDx Point Of Care D-dimer Assay
NCT04737954
LumiraDx UK LimitedDeep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism
Start: 2021-03-18End: 2022-09-30Target: 1000Updated: 2022-09-21
A Performance Evaluation of the LumiraDx Point of Care CRP Assay
CompletedNCT05180110
LumiraDx UK LimitedInfections, Inflammation, Tissue Injury
Start: 2021-11-25End: 2023-05-30Updated: 2023-12-19
A Performance Evaluation of the Lumiradx Point of Care HbA1c Device
CompletedNCT05403853
LumiraDx UK LimitedDiabetes
Start: 2022-04-19End: 2022-10-07Updated: 2024-01-12
Collection of Blood Samples for New Diagnostic Devices 2
RecruitingNCT05568966
LumiraDx UK LimitedCardiovascular, Embolism and Thrombosis, Infections +2
Start: 2022-07-11End: 2026-08-20Target: 20000Updated: 2026-03-05
Frequency of Glucose Monitoring in Labor
CompletedNCT06373432
Icahn School of Medicine at Mount SinaiNeonatal Hypoglycemia
Start: 2024-05-01End: 2025-05-30Updated: 2025-07-02
Glucose Frequent of A1GDM in Labor
CompletedNCT06744621
Icahn School of Medicine at Mount SinaiGestational Diabetes, Controlled by Diet
Start: 2024-12-05End: 2025-05-30Updated: 2025-07-15

Related Papers

Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms.
2022-09-245 citations
Performance Evaluation of the Quantitative Point-of-Care LumiraDx D-Dimer Test.
2021-10-074 citations
A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study.
2021-02-2448 citations